PH Professionals: Submit Your Abstract for PHPN Symposium

2023-03-30T08:59:23-04:00March 29th, 2023|

The Pulmonary Hypertension Association is accepting late-breaking abstract submissions for its PH Professional Network Symposium, Sept. 28-30 in Arlington, Virginia. We’re especially interested in personalization of care, health disparities and treatment access, transition to new therapies, and pediatric PH care.

PHPN Symposium to Feature Lead Author of New PH Guidelines

2023-01-19T09:14:04-05:00January 18th, 2023|

Pulmonary hypertension (PH) health professionals can meet the primary author of recently released PH guidelines at the PH Professional Network Symposium. Dr. Marc Humbert will discuss the new PH guidelines during the Sept. 28-30 PHA event in Arlington, Virginia. The guidelines, developed by a taskforce from the European Society of Cardiology and European Respiratory Society, were published in August 2022.

Apply for new PHA Research Grant

2023-01-05T09:21:06-05:00January 4th, 2023|

The Pulmonary Hypertension Association is accepting applications for a new grant to support junior pulmonary hypertension researchers. Apply now, or spread the word about PHA’s Early Career Mentored Scientist Award. The one-year grant covers up to $65,000 for PH-related research projects that have been favorably reviewed but not funded by the National Institutes of Health. Apply by March 20.

Recall of CADD Infusion Systems Impacts Many PH Patients

2022-12-21T12:31:20-05:00December 21st, 2022|

A manufacturer recall of specific lots of CADD infusion systems recommends against using the affected systems for life-sustaining medication including brand and generic treprostinil (Remodulin) and epoprostenol (Veletri, Flolan).Patients contacted by their specialty pharmacy or PH care team about the issues described below should follow the provided directions immediately.